EQ Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
EQ Wealth Advisors's BMY Position: Q1 2026 in Review
EQ Wealth Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 600 shares — an estimated $32.4K sold.
EQ Wealth Advisors first reported a position in BMY in Q1 2025 and held it in 3 quarters. The position peaked at $36.6K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- EQ Wealth Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- EQ Wealth Advisors sold 600 Bristol-Myers Squibb shares in Q1 2026, an estimated $32.4K.
- EQ Wealth Advisors first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 3 quarters.
- EQ Wealth Advisors's Bristol-Myers Squibb position peaked at $36.6K in Q1 2025.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on EQ Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.